Vimarsana
Biggest News Aggregation in the World

Pharmacy Compounding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmacy Compounding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmacy Compounding Today - Breaking & Trending Today

The Safety of Compounding Pharmacies - Vimarsana News

The Safety of Compounding Pharmacies

Thousands of compounding pharmacies are trusted to mix medications on site. Are they safe?

Source: webmd.com
NCPA joins APC in comments on delays in stability studies under USP Chapter 797 - Vimarsana News

NCPA joins APC in comments on delays in stability studies under USP Chapter 797

NCPA has joined the Alliance for Pharmacy Compounding (APC) in notifying state boards of pharmacy and the FDA of delays in sterile compounding pharmacies fulfilling their requirement that they have completed stability studies for Compounded Sterile Preparations in Category 3.

Source: ncpa.org
World Health Organization: Novo Nordisk tackles harm from Ozempic fakes with global authorities, ET HealthWorld - Vimarsana News

World Health Organization: Novo Nordisk tackles harm from Ozempic fakes with global authorities, ET HealthWorld

The World Health Organization has said global shortages of these drugs is linked to rising reports of suspected counterfeits. Last week, U.S. FDA head Robert Califf said there were likely more cases of online sales of fake obesity drugs than reported.

"Faux-zempic": Behind the rise in fake weight loss drugs that are hospitalizing some people - Vimarsana News

"Faux-zempic": Behind the rise in fake weight loss drugs that are hospitalizing some people

Experts warn against the risks of illegitimately obtained Ozempic and Wegovy

Source: yahoo.com
'Real-time Experiment': Compounded GLP-1s on Coupon Site - Vimarsana News

'Real-time Experiment': Compounded GLP-1s on Coupon Site

Purveyors on coupon sites like Groupon are marketing weight loss programs that include compounded semaglutide and tirzepatide.